168 related articles for article (PubMed ID: 36963483)
1. Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Detailed Description of the Technical Performance, Clinical Utility, and Platform Comparison.
Petrova-Drus K; Syed M; Yu W; Hutt K; Zlotnicki AM; Huang Y; Kamalska-Cyganik M; Maciag L; Wang M; Ma YG; Ho C; Moung C; Yao J; Nafa K; Baik J; Vanderbilt CM; Benhamida JK; Liu Y; Zhu M; Durham B; Ewalt MD; Salazar P; Rijo I; Baldi T; Mato A; Roeker LE; Roshal M; Dogan A; Arcila ME
J Mol Diagn; 2023 Jun; 25(6):352-366. PubMed ID: 36963483
[TBL] [Abstract][Full Text] [Related]
2. Next-CLL, a New Next-Generation Sequencing-Based Method for Assessment of IGHV Gene Mutational Status in Chronic Lymphoid Leukemia.
Bourbon E; Chabane K; Mosnier I; Bouvard A; Thonier F; Ferrant E; Michallet AS; Poulain S; Hayette S; Sujobert P; Huet S
J Mol Diagn; 2023 May; 25(5):274-283. PubMed ID: 36773701
[TBL] [Abstract][Full Text] [Related]
3. A novel next-generation sequencing capture-based strategy to report somatic hypermutation status using genomic regions downstream to immunoglobulin rearrangements.
McCafferty N; Stewart JP; Darzentas N; Gazdova J; Catherwood M; Stamatopoulos K; Langerak AW; Gonzalez D
Haematologica; 2023 May; 108(5):1313-1321. PubMed ID: 36579446
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing.
Davi F; Langerak AW; de Septenville AL; Kolijn PM; Hengeveld PJ; Chatzidimitriou A; Bonfiglio S; Sutton LA; Rosenquist R; Ghia P; Stamatopoulos K;
Leukemia; 2020 Oct; 34(10):2545-2551. PubMed ID: 32561841
[TBL] [Abstract][Full Text] [Related]
5. Single-Step IGHV Next-Generation Sequencing Detects Clonality and Somatic Hypermutation in Lymphoid Malignancies: A Phase III Diagnostic Accuracy Study.
Gazzola A; Navari M; Mannu C; Donelli R; Etebari M; Piccaluga PP
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760593
[TBL] [Abstract][Full Text] [Related]
6. Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia.
Stamatopoulos B; Timbs A; Bruce D; Smith T; Clifford R; Robbe P; Burns A; Vavoulis DV; Lopez L; Antoniou P; Mason J; Dreau H; Schuh A
Leukemia; 2017 Apr; 31(4):837-845. PubMed ID: 27795555
[TBL] [Abstract][Full Text] [Related]
7. Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
Rigolin GM; Saccenti E; Bassi C; Lupini L; Quaglia FM; Cavallari M; Martinelli S; Formigaro L; Lista E; Bardi MA; Volta E; Tammiso E; Melandri A; Urso A; Cavazzini F; Negrini M; Cuneo A
J Hematol Oncol; 2016 Sep; 9(1):88. PubMed ID: 27633522
[TBL] [Abstract][Full Text] [Related]
8. Chronic Lymphocytic Leukemia IGHV Somatic Hypermutation Detection by Targeted Capture Next-Generation Sequencing.
Grants JM; May C; Bridgers J; Huang S; Gillis S; Meissner B; Boyle M; Ben-Neriah S; Hung S; Duns G; Hilton L; Gerrie AS; Marra M; Kridel R; Sabatini PJB; Steidl C; Scott DW; Karsan A
Clin Chem; 2024 Jan; 70(1):273-284. PubMed ID: 38175592
[TBL] [Abstract][Full Text] [Related]
9. High-throughput sequencing using the Ion Torrent personal genome machine for clinical evaluation of somatic hypermutation status in chronic lymphocytic leukemia.
McClure R; Mai M; McClure S
J Mol Diagn; 2015 Mar; 17(2):145-54. PubMed ID: 25554587
[TBL] [Abstract][Full Text] [Related]
10. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
11. Detecting measurable residual disease beyond 10-4 by an IGHV leader-based NGS approach improves prognostic stratification in CLL.
Hengeveld PJ; van der Klift MY; Kolijn PM; Davi F; Kavelaars FG; de Jonge E; Robrecht S; Assmann JLJC; van der Straten L; Ritgen M; Westerweel PE; Fischer K; Goede V; Hallek M; Levin MD; Langerak AW
Blood; 2023 Feb; 141(5):519-528. PubMed ID: 36084320
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of the immunoglobulin heavy chain gene in the diagnosis of primary cutaneous B cell lymphoma.
Child FJ; Woolford AJ; Calonje E; Russell-Jones R; Whittaker SJ
J Invest Dermatol; 2001 Oct; 117(4):984-9. PubMed ID: 11676842
[TBL] [Abstract][Full Text] [Related]
13. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
14. Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma.
Ching T; Duncan ME; Newman-Eerkes T; McWhorter MME; Tracy JM; Steen MS; Brown RP; Venkatasubbarao S; Akers NK; Vignali M; Moorhead ME; Watson D; Emerson RO; Mann TP; Cimler BM; Swatkowski PL; Kirsch IR; Sang C; Robins HS; Howie B; Sherwood A
BMC Cancer; 2020 Jun; 20(1):612. PubMed ID: 32605647
[TBL] [Abstract][Full Text] [Related]
15. Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms.
Arcila ME; Yu W; Syed M; Kim H; Maciag L; Yao J; Ho C; Petrova K; Moung C; Salazar P; Rijo I; Baldi T; Zehir A; Landgren O; Park J; Roshal M; Dogan A; Nafa K
J Mol Diagn; 2019 Mar; 21(2):330-342. PubMed ID: 30590126
[TBL] [Abstract][Full Text] [Related]
16. Next-Generation Sequencing-Based Clonality Assessment of Ig Gene Rearrangements: A Multicenter Validation Study by EuroClonality-NGS.
van den Brand M; Rijntjes J; Möbs M; Steinhilber J; van der Klift MY; Heezen KC; Kroeze LI; Reigl T; Porc J; Darzentas N; Luijks JACW; Scheijen B; Davi F; ElDaly H; Liu H; Anagnostopoulos I; Hummel M; Fend F; Langerak AW; Groenen PJTA;
J Mol Diagn; 2021 Sep; 23(9):1105-1115. PubMed ID: 34186174
[TBL] [Abstract][Full Text] [Related]
17. Detection of Immunoglobulin Heavy Chain Gene Clonality by Next-Generation Sequencing for Minimal Residual Disease Monitoring in B-Lymphoblastic Leukemia.
Shin S; Hwang IS; Kim J; Lee KA; Lee ST; Choi JR
Ann Lab Med; 2017 Jul; 37(4):331-335. PubMed ID: 28445014
[TBL] [Abstract][Full Text] [Related]
18. Reliable IGHV status assessment by next generation sequencing in routine practice for chronic lymphocytic leukemia.
Boulland ML; Vic S; Thonier F; Ganard M; Lamy T; Fest T; Guibert S; Pastoret C
Leuk Lymphoma; 2021 Nov; 62(11):2800-2803. PubMed ID: 34060965
[No Abstract] [Full Text] [Related]
19. Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia.
Visco C; Moretta F; Falisi E; Facco M; Maura F; Novella E; Nichele I; Finotto S; Giaretta I; Ave E; Perbellini O; Guercini N; Scupoli MT; Trentin L; Trimarco V; Neri A; Semenzato G; Rodeghiero F; Pizzolo G; Ambrosetti A
Am J Hematol; 2013 Apr; 88(4):277-82. PubMed ID: 23450508
[TBL] [Abstract][Full Text] [Related]
20. Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia.
Ritgen M; Lange A; Stilgenbauer S; Dohner H; Bretscher C; Bosse H; Stuhr A; Kneba M; Dreger P
Blood; 2003 Mar; 101(5):2049-53. PubMed ID: 12411304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
